Revolutionizing congenital central hypoventilation syndrome screening: the potential of machine learning approaches

Qinchang Chen,Shushui Wang

DOI: https://doi.org/10.1038/s41390-024-03090-x

IF: 3.953

2024-02-11

Pediatric Research

Abstract:Congenital central hypoventilation syndrome (CCHS) is a rare autosomal dominant disorder characterized by central hypoventilation and apnea due to attenuated or absent peripheral and central chemoreceptor responsiveness. 1 CCHS can present at any age, as early as within hours of birth, and sometimes may be misdiagnosed as sudden infant death syndrome (SIDS) due to unexplained prolonged apnea leading to death. 2 Early diagnosis and timely intervention are crucial for long-term prognosis, while there are still a considerable amount of cases remaining undiagnosed worldwide due to the lack of awareness of the disease and the need of genetic testing. The PHOX2B gene stands out as the primary pathogenic gene for CCHS. Genetic testing assumes a crucial role in both diagnosing and managing CCHS, aiding in the prediction of clinical severity, disease staging, and potential complications. Nevertheless, diagnosing CCHS in developing countries, particularly in economically disadvantaged rural areas, poses significant challenges. Similar to various other genetic syndromes, a majority of children affected by CCHS often exhibit abnormal facial features. The advent of machine learning, leveraging distinctive facial characteristics, holds the promise of providing convenient and efficient tools for screening rare genetic syndromes. 3,4 It is noteworthy that, unlike some other genetic syndromes such as Noonan syndrome and Williams syndrome, the facial features associated with CCHS are often less conspicuous. Machine learning has the capability to discern much subtler differences than the human eye alone, presenting an opportunity for disease diagnosis. However, the body of relevant research on this subject remains limited.

pediatrics